A documented breakthrough infection was observed in 136 (29.4%) and 134 (29.8%) of participants with available Spike-specific T cell data for CD4 + (n = 462) and CD8 + (n = 449) T cells, respectively, at day 90. This evidence concerns the gene CD8A and infection.